{"id":"https://openalex.org/W1978625892","doi":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","title":"Agonist and Antagonist Properties of \u03b23\u2010Adrenoceptors in Human Omental and Mouse 3T3\u2010L1 Adipocytes","display_name":"Agonist and Antagonist Properties of \u03b23\u2010Adrenoceptors in Human Omental and Mouse 3T3\u2010L1 Adipocytes","publication_year":1996,"publication_date":"1996-04-01","ids":{"openalex":"https://openalex.org/W1978625892","doi":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","mag":"1978625892","pmid":"https://pubmed.ncbi.nlm.nih.gov/8861784"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0773.1996.tb00214.x","doi":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","pdf_url":null,"source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111994956","display_name":"Manabu Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Manabu Shimizu","raw_affiliation_strings":["Department of Medicine, Huddinge University Hospital, Karolinska Institute, Sweden","Departments of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Huddinge University Hospital, Karolinska Institute, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Departments of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081222354","display_name":"Ellen E. Blaak","orcid":"https://orcid.org/0000-0002-2496-3464","observed_orcids":["https://orcid.org/0000-0002-2496-3464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen E. Blaak","raw_affiliation_strings":["Departments of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071018999","display_name":"Fredrik L\u00f6nnqvist","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fredrik L\u00f6nnqvist","raw_affiliation_strings":["Departments of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109858615","display_name":"Mats E. G\u00e5fvels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mats E. G\u00e5fvels","raw_affiliation_strings":["Departments of Medicine","Molecular Nutrition and Reserch Centre, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine","institution_ids":[]},{"raw_affiliation_string":"Molecular Nutrition and Reserch Centre, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064986157","display_name":"Peter Arner","orcid":"https://orcid.org/0000-0002-6208-6220","observed_orcids":["https://orcid.org/0000-0002-6208-6220"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Peter Arner","raw_affiliation_strings":["Departments of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5064986157"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1055,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.33637455,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"78","issue":"4","first_page":"254","last_page":"263"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11457","display_name":"Adipose Tissue and Metabolism","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta3-adrenergic-receptor","display_name":"beta3-adrenergic receptor","score":0.8889999985694885},{"id":"https://openalex.org/keywords/lipolysis","display_name":"lipolysis","score":0.7120000123977661},{"id":"https://openalex.org/keywords/omental-adipocytes","display_name":"omental adipocytes","score":0.8259999752044678},{"id":"https://openalex.org/keywords/3t3-l1-adipocytes","display_name":"3T3-L1 adipocytes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cgp-12177","display_name":"CGP 12177","score":0.9240000247955322},{"id":"https://openalex.org/keywords/beta-adrenergic-agonists","display_name":"beta-adrenergic agonists","score":0.7900000214576721},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9869999885559082},{"id":"https://openalex.org/keywords/catecholamines","display_name":"catecholamines","score":0.7860000133514404},{"id":"https://openalex.org/keywords/intrinsic-activity","display_name":"intrinsic activity","score":0.5759999752044678},{"id":"https://openalex.org/keywords/species-comparison","display_name":"species comparison","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7657228708267212},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7476402521133423},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7053661942481995},{"id":"https://openalex.org/C2776090920","wikidata":"https://www.wikidata.org/wiki/Q415550","display_name":"Isoprenaline","level":3,"score":0.6739945411682129},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6286699175834656},{"id":"https://openalex.org/C38533456","wikidata":"https://www.wikidata.org/wiki/Q1671589","display_name":"Intrinsic activity","level":4,"score":0.584947407245636},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.5696544051170349},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5517732501029968},{"id":"https://openalex.org/C2776175234","wikidata":"https://www.wikidata.org/wiki/Q357519","display_name":"Adipocyte","level":3,"score":0.543714702129364},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4957650601863861},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46256741881370544},{"id":"https://openalex.org/C140985366","wikidata":"https://www.wikidata.org/wiki/Q898489","display_name":"Lipolysis","level":3,"score":0.4490922689437866},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41264063119888306},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3336185812950134},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31346553564071655},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.2151378095149994},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19271957874298096},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15867188572883606},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.12574544548988342},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09832018613815308}],"mesh":[{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007545","descriptor_name":"Isoproterenol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008066","descriptor_name":"Lipolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008066","descriptor_name":"Lipolysis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009852","descriptor_name":"Omentum","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011943","descriptor_name":"Receptors, Adrenergic, beta","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D022702","descriptor_name":"Receptors, Adrenergic, beta-3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1600-0773.1996.tb00214.x","doi":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","pdf_url":null,"source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & Toxicology","raw_type":"journal-article"},{"id":"pmid:8861784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8861784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & toxicology","raw_type":"Comparative Study"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire_cris_publications/f021c85c-024d-4484-b68e-e2f8312bc249","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/f021c85c-024d-4484-b68e-e2f8312bc249","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Shimizu, M, Blaak, E E, Lonnqvist, F, Gafvels, M & Arner, P 1996, 'Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.', Pharmacology & Toxicology, vol. 78, pp. 254-263. https://doi.org/10.1111/j.1600-0773.1996.tb00214.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/f021c85c-024d-4484-b68e-e2f8312bc249","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/f021c85c-024d-4484-b68e-e2f8312bc249","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology & Toxicology, 78, 254 - 263. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322128","display_name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","ror":"https://ror.org/0433fd238"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"},{"id":"https://openalex.org/F4320324618","display_name":"Svenska L\u00e4kares\u00e4llskapet","ror":"https://ror.org/016ks4x90"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W109691321","https://openalex.org/W1492102604","https://openalex.org/W1495418160","https://openalex.org/W1520083061","https://openalex.org/W1545777282","https://openalex.org/W1555931521","https://openalex.org/W1574139946","https://openalex.org/W1777337468","https://openalex.org/W1795391938","https://openalex.org/W1829813730","https://openalex.org/W1860245890","https://openalex.org/W1899712492","https://openalex.org/W1923677208","https://openalex.org/W1946645080","https://openalex.org/W1968708631","https://openalex.org/W1971435173","https://openalex.org/W1981047025","https://openalex.org/W1987074453","https://openalex.org/W1987718519","https://openalex.org/W1990451815","https://openalex.org/W1991217198","https://openalex.org/W1993096445","https://openalex.org/W1995719809","https://openalex.org/W1995845268","https://openalex.org/W1996972993","https://openalex.org/W2000421464","https://openalex.org/W2002896923","https://openalex.org/W2006155400","https://openalex.org/W2008301372","https://openalex.org/W2008580525","https://openalex.org/W2010572990","https://openalex.org/W2015912619","https://openalex.org/W2016439024","https://openalex.org/W2022923290","https://openalex.org/W2026399791","https://openalex.org/W2028671417","https://openalex.org/W2047965877","https://openalex.org/W2054019567","https://openalex.org/W2058462966","https://openalex.org/W2059022408","https://openalex.org/W2067153967","https://openalex.org/W2082058674","https://openalex.org/W2094115400","https://openalex.org/W2108088417","https://openalex.org/W2117821842","https://openalex.org/W2121162804","https://openalex.org/W2121206824","https://openalex.org/W2123091473","https://openalex.org/W2143873575","https://openalex.org/W2146726412","https://openalex.org/W2189424535","https://openalex.org/W2280222586","https://openalex.org/W2337739130","https://openalex.org/W2403361849","https://openalex.org/W2408151221","https://openalex.org/W2410256428","https://openalex.org/W4285719527","https://openalex.org/W4416702841"],"related_works":["https://openalex.org/W2047965877","https://openalex.org/W2108088417","https://openalex.org/W1860245890","https://openalex.org/W2141454843","https://openalex.org/W1810595548","https://openalex.org/W64650861","https://openalex.org/W1946645080","https://openalex.org/W4406057066","https://openalex.org/W2412605060","https://openalex.org/W2170808351"],"abstract_inverted_index":{"The":[0,91,139,209],"pharmacological":[1,70,231],"properties":[2,20,232],"of":[3,21,41,57,88,93,95,104,126,128,141,233,248],"the":[4,13,16,37,61,64,124,129,133,142,199,230,245],"native":[5],"human":[6,25,62,116,249],"beta":[7,22,78,105,107,134,137,143,179,181,246],"3-adrenoceptor":[8,79,144,201],"are":[9,241],"poorly":[10],"defined.":[11],"In":[12,228],"present":[14],"study,":[15],"agonist":[17,80],"and":[18,27,63,109,117,161,183,192,216,222,238,252],"antagonist":[19],"3-adrenoceptors":[23,247],"in":[24,36,54,69,81,114,155,167,204,225],"omental":[26,250],"mouse":[28,65],"3T3-L1":[29,118,253],"adipocytes":[30,251],"were":[31,51,152,163,202,218],"compared":[32],"by":[33],"measuring":[34],"lipolysis":[35],"absence":[38],"or":[39,136,175],"presence":[40],"adrenoceptor":[42,98],"blockers.":[43],"Methodological":[44],"experiments":[45],"revealed":[46],"that":[47],"all":[48],"three":[49],"beta-adrenoceptors":[50],"functionally":[52],"expressed":[53,148],"both":[55,82,115,156,168,205,226],"types":[56,84,170],"adipocytes.":[58,119,254],"This":[59,120],"makes":[60],"cells":[66],"directly":[67],"comparable":[68],"studies.":[71],"CGP":[72,194,239],"12177":[73,195,240],"was":[74,112],"a":[75,86],"selective":[76],"partial":[77],"cell":[83,169],"with":[85],"pD(2)":[87,150],"about":[89,219],"7.5.":[90],"order":[92,125],"potency":[94,127],"classical":[96,234],"non-selective":[97],"agonists,":[99],"when":[100],"determined":[101],"during":[102,177],"blockade":[103],"1-,":[106],"2-":[108,182],"alpha":[110,184,200],"2-adrenoceptors,":[111],"isoprenaline>noradrenaline>adrenaline":[113],"is":[121],"different":[122],"from":[123,173],"same":[130],"agonists":[131,166],"at":[132,198,244],"1-":[135],"2-adrenoceptors.":[138],"sensitivity":[140],"to":[145],"these":[146],"catecholamines,":[147,235],"as":[149,190,196],"values,":[151],"virtually":[153],"identical":[154,243],"adipocyte":[157,206],"types.":[158],"Isoprenaline,":[159],"noradrenaline,":[160],"adrenaline":[162],"almost":[164,242],"full":[165],"(intrinsic":[171],"activity":[172],"74%":[174],"95%)":[176],"combined":[178],"1,":[180],"2-adrenoceptor":[185],"blockade.":[186],"Antagonist":[187],"potencies":[188],"(expressed":[189],"pA(2)":[191,211],"using":[193],"agonist)":[197],"similar":[203],"types:":[207],"bupranolol>propranolol>metoprolol.":[208],"corresponding":[210],"values":[212],"for":[213],"bupranolol,":[214],"propanolol":[215],"metoprolol":[217],"7,":[220],"6":[221],"5,":[223],"respectively":[224],"species.":[227],"conclusion,":[229],"beta-adrenoceptor":[236],"blockers":[237]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2016-06-24T00:00:00"}